Image via PRN — Human Resources / Workforce
Last updated
Insulet Corporation: Restructuring
Manufacturing issues at Insulet's Acton facility led to medical device corrections affecting millions of insulin pump pods. SEC filings had previously claimed quality assurance inspections at various manufacturing steps, creating disclosure gap and triggering investor litigation.
The leadership read
Restructuring typically reshapes medtech leadership bench strength toward transformation and turnaround capability.
Market context: Against a Talent Market Index of 107.8 (Hot) (up 2.4 month-on-month), Americas is at rising (+15.4pts) on signal share.
Insulet Corporation: 1 signal in the last 90 days — in line with the MedTech median of 1 across 21 tracked companies.
From the MitchelLake archive
More signals across MedTech
Partnership · Americas
Olympus Corporation →Olympus Corporation announced a 3-year reseller agreement in May 2026 making First Nation Group an authorized Service-Disabled Veteran-Owned Small Business reseller. This partnership provides federal healthcare providers streamlined access to Olympus capital equipment and single-use medical devices across gastroenterology, urology, respiratory and surgical specialties.
Leadership Change · Americas
Illumina →Illumina appoints Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, to its Board of Directors, effective June 16, 2026.
Ma Activity · Americas
Medtronic →Medtronic completed a $550M acquisition of Scientia Vascular, expanding its vascular intervention and treatment capabilities
Capital Raising · Americas
Perimeter Medical Imaging AI, Inc. →Perimeter Medical Imaging AI filed Form D for private placement, indicating capital raising activity
Ma Activity · Americas
Analog Devices →In talks to acquire Empower Semiconductor for $1.5 billion, focusing on AI chip power management
Intelligence powered by Autonodal ↗